References + Milestones

Many years of experience

For 30 years Polypharma has been successfully supporting generic drug manufacturers in various countries in Africa and the Middle East and ensuring their supply of raw materials (APIs).

We have registered more than 150 dossiers covering a wide range of therapeutic treatments and all pharmaceutical forms.

Polypharma is EUDRA-GMDP and ISO 9001 certified and ensures compliance with quality standards such as ICH guidelines, GMP, Pharmacopoeia and DMF.

Benefit from reliable dossiers

Over the years we have acquired knowledge of the regulatory requirements in various countries. We put this knowledge at generic manufacturers’ disposal and assist them until they obtain marketing authorisation.

If you’d like to expand your generic product range or set up a pharmaceutical company, turn pharmaceutical possibilities into realities: Contact us.

Milestones

M

Until today

A large number of dossiers including all pharmaceutical forms developed by Polypharma and registered by our partners

6

2021

Polypharma celebrates 30th anniversary

6

2018 – 2020

Establishment of a new pharmaceutical factory in Algeria

6

2018

Focus on the development of new dossiers for dry forms, such as tablets, capsules and dry powder inhaler

6

2016

Registration of first corticoid dossiers by our partners

6

2015

First dossiers developed with anaesthetics in dual and triple therapy
Polypharma adds to its activities the exclusive representation of a HPLC columns producer for Germany and North Africa

6

2014

Development of new corticoid dossiers in the form of tablets and oral solutions

6

2013

Focus on the development of technical dossiers in the field of dual and triple therapies
Expansion of the product portfolio to include veterinary dossiers
Polypharmas first time as exhibitor at the fair CPhI Worldwide

6

2011

Development of quinolone antibiotics in tablet form

6

2008

Creation of dossiers with neuroleptics as suppositories and tablets as well as development of the first corticoid cream

6

2007

Expansion of the private pharmaceutical sector in Algeria
North Africa: first market approvals of eye and nose drops by our partners

6

2006

Development of the first dossiers for ophthalmic and nasal solutions as well as new technical dossiers for capsules.
First creation of β-lactam antibiotics in powder form to produce oral suspension

6

2005

Expansion of the portfolio of cardiovascular dossiers

6

2003

Morocco: first market approvals of Polypharma dossiers by partners
At the same time, a Tunisian pharmaceutical company registers antihistamine generics dossiers

6

2002

Tunisia: registration of the first dossiers with Pseudoephedrine, injectable solutions and a first anti-haemorrhoid cream
2001

6

2001

Polypharma creates dossiers for dual and triple therapy (antiarrhythmic & cardiovascular) as well as anti-diabetic drugs

6

2000

Obtain approval for the commercialisation of Narcotics and Category I Precursors, beginning with the first deliveries

6

1999

Participation in a project to build a Learning Centre in Burundi (the project had to be interrupted due to unrest in the country)

6

1996

Registration of first Polypharma dossiers

6

1995

Development of vaginal suppositories, suspensions, syrups and injectable

6

1994

Development of dossiers for dry, pastes and semi-solid dosage forms

6

1993

Change of name to Polypharma Technologies & Sciences GmbH
Expansion of business area to include the development of generic drug dossiers and DMFs

6

1991

Foundation of the company Polypharma Import Export GmbH
Resumption and development of trade relations previously established in various countries in Africa and the Middle East.

6

Before 1991

In the years preceding the creation of Polypharma, its founder gained experience in accompanying, among others, the following projects:
Mali:

supervision of the reorganisation of a pharmaceutical factory, setting up a production line for infusion and a first local production line for generic syrups and tablets for the battle against malaria.

Tunisia:

support during the production of various finished products in various pharmaceutical forms.

Burundi and Rwanda:

implementation of generic antimalarial drugs and macrolide antibiotics

Algeria:

assistance in production, registration of technical dossiers and realisation of several finished products in different sites

Syria:

manufacturing of various pharmaceutical products

News

Glossary

Polypharma
Technologies & Sciences GmbH

Grosse Reichenstrasse 27
20457 Hamburg
Germany
+49 (0)40 37 480 3-0
info[at]polypharma.de